VIVUS

$4.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.00 (-0.12%) As of 2:54 PM EDT today
-$0.00 (-0.12%) Today

Why Robinhood?

You can buy or sell VIVUS and other stocks, options, ETFs, and crypto commission-free!

About VVUS

VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Read More Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.

Employees
57
Headquarters
Campbell, California
Founded
1991
Market Cap
45.87M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
85.17K
High Today
$4.37
Low Today
$4.23
Open Price
$4.32
Volume
148.82K
52 Week High
$5.78
52 Week Low
$2.15

Collections

VVUS Earnings

-$1.17
-$0.81
-$0.46
-$0.10
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 29, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.